The FDA (American drug agency) has approved today the use of the first automatic artificial pancreas, called Minimed 670G and works as an insulin dumb.
Technology, science and innovation seek to improve the living conditions of people suffering from diabetes.Now, the confirmation of the approval of the use of a new device called Minimed 670G constitutes a great advance for those who suffer from this metabolic disease.
Type 1 diabetes requires that patients injected insulin to have it controlled.This automatic artificial pancreas works as an insulin pump that connects wirelessly with a subcutaneous sensor that measures the blood sugar level.This is able to inject the necessary doses of insulin continuously and automatically without the user having to perform any action.
The edible battery that will allow to diagnose diseases from within
The only essential thing is to estimate the amount of carbohydrates that the device user will ingest with the meals so that the pump compensates for said intake.The Minimed 670G has been approved, for now, for patients over 14 years, although a study is underway to determine whether its use in children 6 years of age there is possible.
an intelligent algorithm
In addition to the operation and automatic monitoring, its manufacturer has revealed that the Minimed 670G algorithm progressively learns data about the user, which allows him to optimize his adjustments much more accurately than with the traditional insulin injections.
People with diabetes who have been part of the clinical study prior to their approval by the US health authority (FDA) have managed to lower their A1C level (glucosylated hemoglobin), a long -term indicator of the blood sugar level, and in addition, they have managed to reduce by 44 percent and 11 percent the time they spend with low and high sugar levels respectively compared to the values obtained when they carried out control of the sugar level manually.
It is still necessary to improve the system, since you have to change the sensor manually and perform periodic calibrations.Of course, the tube by which the device injects insulin can be used between two and three years and the pump is submersible.
Now, the future challenge is the design of an artificial pancreas that can be implemented in the patient's body.For now, this 670g minimed is a great solution for diabetics.In the following infographic you can see the operation of the device summarized.
This is how Minimed 670g works for type 1 diabetics